GlassScriptPhysician profile
Rolando Molina
NPI 1265469225
$5,608.86
in general payments reported to CMS, 2019-2025
29 companies · $1,212 in 2025
The $1,212 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $382 · 2021: $715 · 2022: $526 · 2023: $986 · 2024: $1,238 · 2025: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,337 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,337.22 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,975.79 | 2019-2025 | Inspire |
| Genzyme Corporation | $883.54 | 2019-2025 | |
| Aerin Medical INC. | $576.81 | 2020-2023 | |
| Glaxosmithkline, LLC. | $519.82 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $449.88 | 2022-2025 | Dupixent |
| Optinose US, INC. | $288.17 | 2019-2025 | |
| Acclarent, INC | $156.16 | 2021-2023 | Relieva Spinplus |
| Calliditas Therapeutics US INC. | $86.22 | 2025 | Tarpeyo |
| Smith+Nephew, INC. | $69.45 | 2025 | Stravix, Grafix Pl, Oasis |
| Arrinex, INC. | $69.40 | 2019 | |
| Endo Pharmaceuticals INC. | $59.60 | 2023 | Xiaflex, Aveed |
| Medtronic, INC. | $58.32 | 2024-2025 | Nuvent, Stealthstation S8 Platform |
| Intersect Ent, INC. | $53.46 | 2019 | |
| Integra Lifesciences Corporation | $39.66 | 2021 | |
| Alk-Abello, INC | $34.95 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31.85 | 2019 | |
| Lilly USA, LLC | $30.60 | 2025 | Zepbound, Mounjaro |
| Coopersurgical, INC. | $29.62 | 2025 | Onetrac Lx |
| Ars Pharmaceuticals Operations, INC. | $23.51 | 2025 | Neffy |
| Kaleo, INC. | $19.56 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.01 | 2019 | |
| Checkpoint Surgical, INC | $19.00 | 2023 | Checkpoint Stimulators |
| Cook Medical LLC | $18.71 | 2020 | |
| Mylan Pharmaceuticals INC. | $18.12 | 2020 | |
| Stryker Corporation | $17.39 | 2021 | |
| Aroa Biosurgery Incorporated | $16.31 | 2024 | |
| Hologic Sales and Service, LLC | $15.15 | 2023 | Coolseal Generator |
| Hikma Pharmaceuticals USA | $14.40 | 2024 | Ryaltris |
| Medtronic USA, INC. | $14.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolando Molina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.